Form 4: Corcept Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Joseph Douglas Lyon, See Remarks of Corcept Therapeutics Inc, sold 1,540 shares of common stock on August 3, 2026 for $114.16 per share.
Summary
- Open-market sale: disposed of 1,540 Common Stock at $114.16 ($175,806) on August 3, 2026; holds 5,495 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $175,806 of stock on the open market.
Insider Transactions
Joseph Douglas Lyon — Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Open-market sale | Common Stock | 1,540 | $114 | $175.8K | 5,495 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Open-market sale (1,540 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Joseph Douglas Lyon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.